| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f7ddc4774cf5f8a0bda44a780d73c53d |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B41J2-17553
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B41J2-17556
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1623
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1611
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1652
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1635 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5042
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5047
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B41J2-17506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5026 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38 |
| filingDate |
2004-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_84f8b30eef0cc4d8f09b1d2ace04ba78
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7997126de7f7e531e4bb5a8f94f1d3a2 |
| publicationDate |
2005-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20050082038-A |
| titleOfInvention |
Tamsulosin hydrochloride composition for oral administration and controlled-release granule formulation thereof |
| abstract |
The present invention relates to a composition for oral administration of tamsulosin hydrochloride comprising tamsulosin hydrochloride, polyvinylacetate and water-soluble hydroxypropylmethylcellulose, and a sustained release granule formulation thereof, wherein the composition according to the present invention is pharmaceutically stable. In addition, it is possible to effectively maintain a constant release rate and effective blood concentration in the gastrointestinal tract of the active ingredient can be useful for oral administration of tamsulosin hydrochloride. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016133333-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20180018450-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20160100570-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20180008339-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20170073580-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018012931-A1 |
| priorityDate |
2004-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |